Drug and Therapeutics Bulletin 1995;33:45-47; doi:10.1136/dtb.1995.33645
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Allergen testing in patients with type I hypersensitivity

Around 1 in 6 people have some form of allergy.1 The more common presentations include seasonal and perennial rhinitis, acute urticaria, immediate reactions to food and drugs and the early phase of atopic eczema and asthma. All of these are IgE mediated and classified as immediate (type I) hypersensitivity. Other presentations of hypersensitivity include transfusion reactions (type II; antibody reactions with antigens on cell surfaces), farmer's lung and bird fancier's disease (type III; immune complex-mediated reactions) and contact dermatitis and fixed drug eruptions like late reactions to antibiotics (type IV; delayed-type cell-mediated reactions).2 In this article we review the tests used for investigating patients with suspected type I hypersensitivity and consider their value in management.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.